Bill > HR7017

This bill, called the Right to Test Act, would allow states to approve the use of diagnostic tests during a public health emergency, overriding certain federal regulations. Specifically, the bill would permit state public health departments or other designated state entities to clear or approve diagnostic tests or devices for use within their state during a declared public health emergency, without needing approval from the federal Food and Drug Administration (FDA). The bill would also suspend the FDA's ability to take enforcement actions against states, healthcare providers, laboratories, and others who prepare, manufacture, or use such state-approved tests within the state. Finally, the bill requires the FDA to review and make a determination on any state-approved tests that have not been federally cleared or approved within 180 days after the end of the public health emergency.

Business and Industry

https://www.congress.gov/bill/116th-congress/house-bill/7017/all-info